Float Bio raises $140K from MYSC for point-of-care bladder cancer diagnostic kit BLOOM.
Amount Raised
$140,000
Round Type
Pre-Seed
South KoreaBiotechnologyHealth CareTherapeuticsHealth DiagnosticsInvestors
Description
Float Bio, a diagnostic startup, has secured approximately $140,000 (200 million won) in investment from MYSC through the KAIST-MISC Double Impact Fund. The company was selected for MYSC's 2026 EMA Original in-house investment batch program. Float Bio develops disease diagnostic kits using enzyme biomarker amplification technology, with its first product BLOOM being a point-of-care test for bladder cancer screening. The company plans to expand its diagnostic platform to other diseases including periodontal disease and pancreatic cancer.
Who else raised in Therapeutics and Health Diagnostics around the same time
Companies in the same sectors as Float Bio that raised within 45 days of this round, from Fundz verified event records.
- VolitionRx raised $2.4M (Convertible Note) on October 27, 2026.
- Pathos AI raised $237M (Series E) on October 23, 2026.
- Cerenome, Inc. raised $20M (Debt Financing) on September 10, 2026.
- Cerenome, Inc. raised $3M (Post-IPO Equity) on September 10, 2026.
- Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
- Orakl Oncology raised $34M (Series A) on November 12, 2026.
Who to call at Float Bio, and when
A new round usually means Float Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Float Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Float Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Float Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Float Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Float Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.